Loading…
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $925M | $82M | $11M | $9M | 1.8% | 8.3% | -74.4% |
| 2024 | $855M | $99M | $42M | $51M | 7.2% | -7.2% | -34.1% |
| 2023 | $921M | $123M | $64M | $56M | 12.8% | -7.8% | -8.0% |
| 2022 | $999M | $130M | $69M | $94M | 16.0% | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total Revenue | 998.60 | 921.01 | 854.50 | 925.26 |
| Cost Of Revenue | 193.89 | 176.69 | 161.21 | 200.85 |
| Gross Profit | 804.71 | 744.32 | 693.29 | 724.40 |
| Operating Expense | 697.10 | 651.25 | 626.97 | 673.54 |
| Operating Income | 107.61 | 93.07 | 66.32 | 50.86 |
| EBITDA | 130.22 | 123.11 | 98.86 | 82.07 |
| EBIT | 108.81 | 102.72 | 76.63 | 42.37 |
| Pretax Income | 108.62 | 102.45 | 76.35 | 41.53 |
| Tax Provision | 39.27 | 38.66 | 34.29 | 30.05 |
| Net Income | 69.35 | 63.79 | 42.03 | 10.76 |
| Net Income Common Stockholders | 69.35 | 63.79 | 42.03 | 10.76 |
| Total Expenses | 890.99 | 827.94 | 788.18 | 874.39 |
| Interest Expense | 0.19 | 0.26 | 0.28 | 0.84 |
| Interest Income | 3.79 | 9.64 | 11.32 | 2.42 |
| Selling General And Administration | 262.30 | 256.99 | 263.27 | 337.37 |
| Normalized EBITDA | 130.22 | 123.11 | 98.86 | 95.50 |
| Normalized Income | 69.35 | 63.79 | 42.03 | 18.82 |
| Basic EPS | 3.61 | 3.33 | 2.21 | 0.58 |
| Diluted EPS | 3.59 | 3.30 | 2.19 | 0.58 |
| Tax Effect Of Unusual Items | 0 | 0 | 0 | -5.37 |
| Tax Rate For Calcs | 0.36 | 0.38 | 0.21 | 0.40 |
| Total Unusual Items | 0 | 0 | 0 | -13.43 |
| Total Unusual Items Excluding Goodwill | 0 | 0 | 0 | -13.43 |
| Net Income From Continuing Operation Net Minority Interest | 69.35 | 63.79 | 42.03 | 10.76 |
| Reconciled Depreciation | 21.41 | 20.39 | 22.23 | 39.70 |
| Reconciled Cost Of Revenue | 193.89 | 176.69 | 161.21 | 200.85 |
| Net Interest Income | 3.60 | 9.38 | 11.04 | 1.57 |
| Net Income From Continuing And Discontinued Operation | 69.35 | 63.79 | 42.03 | 10.76 |
| Total Operating Income As Reported | 107.61 | 93.07 | 66.32 | 37.43 |
| Diluted Average Shares | 19.31 | 19.34 | 19.16 | 18.57 |
| Basic Average Shares | 19.21 | 19.13 | 19.06 | 18.54 |
| Diluted NI Availto Com Stockholders | 69.35 | 63.79 | 42.03 | 10.76 |
| Minority Interests | 0 | 0 | -0.03 | -0.72 |
| Net Income Including Noncontrolling Interests | 69.35 | 63.79 | 42.06 | 11.48 |
| Net Income Continuous Operations | 69.35 | 63.79 | 42.06 | 11.48 |
| Other Income Expense | -2.59 | 0.01 | -1.01 | -10.91 |
| Other Non Operating Income Expenses | -2.59 | 0.01 | -1.01 | 2.52 |
| Special Income Charges | 0 | 0 | 0 | -13.43 |
| Other Special Charges | 0 | 0 | 0 | 6.46 |
| Impairment Of Capital Assets | 0 | 0 | 0 | 6.97 |
| Net Non Operating Interest Income Expense | 3.60 | 9.38 | 11.04 | 1.57 |
| Interest Expense Non Operating | 0.19 | 0.26 | 0.28 | 0.84 |
| Interest Income Non Operating | 3.79 | 9.64 | 11.32 | 2.42 |
| Other Operating Expenses | 434.79 | 394.26 | 363.70 | 336.17 |
| Selling And Marketing Expense | 434.79 | 394.26 | 0 | 0 |
| General And Administrative Expense | 262.30 | 256.99 | 263.27 | 337.37 |
| Other Gand A | 262.30 | 256.99 | 263.27 | 337.37 |
| Operating Revenue | 998.60 | 921.01 | 854.50 | 925.26 |
Consumer Defensive sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| USANA Health Sciences, Inc.this co. | USNA | - | - | - | 1.8% | - |
| Waldencast plc | WALD | $98M | - | 0.20 | -45.9% | -42.73 |
| Solesence, Inc. | SLSN | $92M | 65.00 | 5.20 | 10.2% | 46.52 |
| Zevia PBC | ZVIA | $90M | - | 1.65 | -27.9% | -5.05 |
| FitLife Brands, Inc. | FTLF | $87M | 14.70 |
| 1.99 |
| 14.5% |
| 9.60 |
| Ispire Technology Inc. | ISPR | $76M | - | -9.85 | -6489.3% | -1.88 |
| LifeVantage Corporation | LFVN | $65M | 8.42 | 1.96 | 28.3% | 5.53 |
| Skillsoft Corp. | SKIL | $60M | - | -1.97 | 462.6% | 7.01 |
| The Hain Celestial Group, Inc. | HAIN | $58M | - | 0.18 | -111.8% | 8.05 |
| Peer Median | - | 14.70 | 0.92 | -8.9% | 6.27 | |